Pfizer is to invest $200m to improve the company’s biotechnology manufacturing plant in Clondalkin, County Dublin, Ireland.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The company’s Grange Castle facility will receive two new processing suites in order to expand its production and testing capacity, enhancing on the capabilities of what is already one of the world’s largest biotech facilities.

Pfizer CFO Frank D’Amelio noted that Ireland is a prime location for major investment, citing the fact that pharmaceutical and chemical products account for over 50% of Irish exports.

Pfizer currently produces two blockbuster products at the Grange Castle plant – pneumococcal disease vaccine Prevnar and arthritis medication Enbrel.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now